ABSTRACT Dietary flavonoids possess a wide spectrum of biochemical and pharmacological actions and are assumed to protect human health. These actions, however, can be antagonistic, and some health claims are mutually exclusive. The antiapoptotic actions of flavonoids may protect against neurodegenerative diseases, whereas their proapoptotic actions could be used for cancer chemotherapy. This study was undertaken to determine whether a cytoprotective dose range of flavonoids could be differentiated from a cytotoxic dose range.
Flavonoids are polyphenolic compounds that occur ubiquitously in foods of plant origin; Ͼ6000 flavonoids, low-molecular-weight phenylbenzopyrones, have been identified in plant sources. This class of compounds has become increasingly popular in terms of health protection because they possess a remarkable spectrum of biochemical and pharmacologic activities (1) . Flavonoids affect basic cell functions such as growth, differentiation, and apoptosis. Epidemiologic studies have suggested that flavonoids may protect against various stages of the cancer process and are associated with a reduced incidence of coronary heart disease (2, 3) . Flavonoids were shown to be potent antioxidants because of their radical-scavenging activity. It was also shown that flavonoids are able to complex heavy metal ions, e.g., iron and copper, which are involved in Fenton-like reactions (4) . The biological actions of flavonoids have long been thought to be due to their antioxidant potential but at present, it is by no means clear whether other mechanisms of action contribute to their overall effect or are even more important than their radical-scavenging properties.
Although some flavonoids act as powerful antioxidants, it was also shown that in high concentrations, they can generate reactive oxygen species by autoxidation and redox-cycling (5-9). Consequently, many reports described adverse actions of flavonoids on a cellular level. For a number of the flavonoids used in this study, cytoprotective as well as cytotoxic and proapoptotic effects were shown in various cell culture models. Thus, protection against apoptotic stimuli was found with quercetin (10), epicatechin (11) , and rutin (12) but on the other hand, induction of apoptosis was described for quercetin (13, 14) , fisetin (15) , morin (16) , myricetin (17) , and rutin (16) . In the comet assay, a protection against DNA strand breaks was demonstrated for quercetin (18, 19) , myricetin (19, 20) , and rutin (20, 21) ; however, strand breaks were also induced by quercetin (18, 22) and myricetin (22) in that assay. Given this wide spectrum of biological actions, it is quite understandable that numerous health claims that are in part mutually exclusive have been linked with flavonoids. Notably, in cancer, but also in infections or autoimmune disease, a deficiency in apoptosis is one of the key events. On the other hand, overefficient apoptosis, as observed in fulminant liver failure, or the long-term accumulation of apoptotic events in neurodegenerative disorders may be equally harmful to the organism.
Given that both beneficial and adverse effects can in principle be caused by flavonoids, it must be assumed that in addition to the cell type or tissue involved and to the presence or absence of a stressor, dose determines which action prevails. Dose dependency, however, has not been studied systematically. The importance of the chemical structure of the flavonoids in relation to their biological activity is also far from obvious. Dietary flavonoids are predominantly present in a glycosidic form, e.g., in fruits (23), although free flavonoids also occur, e.g., myricetin in red wine. The basic structure of flavonoids consists of an O-heterocyclic ring (C) fused to an aromatic ring (A) with a third ring system (B) attached at C2 of the heterocyclic ring. Out of the great variety of structures, we selected 7 representative flavonoids to investigate their pro-and antioxidative effects and their pro-and antiapoptotic properties (Fig. 1) . Quercetin, a major flavonoid in the diet, can be regarded as the lead structure. The structures of the other flavonoids differ from quercetin in the number and position of hydroxy substituents (fisetin, morin, myricetin), the C2-C3 double bond (taxifolin) or the existence of a glycoside moiety (rutin). In the case of (Ϯ)-catechin, the only flavanol analyzed, no 4-keto oxygen or C2-C3 double bond is present.
Because flavonoids are not marketed as drugs, they have seldom been subjected to the stringent pharmacologic and toxicological testing protocols of drug authorization. Instead, flavonoids are marketed as components of functional food and as flavonoid-containing food supplements, thus avoiding toxicological testing. The aim of this study was to collect data on the dose-response relation of protective and adverse effects of flavonoids in a cell culture model to test the hypothesis that adverse effects occur at higher dose levels than protective effects. This effort was undertaken to contribute to the urgently needed risk assessment for the use of high-dose flavonoid food supplements.
MATERIALS AND METHODS
Chemicals. Quercetin, fisetin, rutin, catechin, and taxifolin were purchased from Sigma, morin was obtained from Merck, and myricetin was purchased from Calbiochem; caspase substrates were obtained from ICN Biomedicals.
Cell culture. The metabolically active and differentiated rat H4IIE hepatoma cell line was used as a model system for further experiments in vivo on the influence of flavonoids on enzyme activation in rat liver. Cells were grown in DMEM (4.5 g/L glucose, 2 mmol/L L-glutamine, 100 kU/L penicillin and 100 mg/L streptomycin, and 10% fetal calf serum) in a humidified atmosphere at 37°C with 5% CO 2 .
Cellular uptake of flavonoids. We used HPLC (Eurosphere C-18, photodiode array detector) to investigate intracellular concentrations of flavonoids as described earlier (24) . HPLC-MS-MS was performed to analyze the formation of flavonoid metabolites. The intracellular distribution of quercetin was analyzed by fluorescence microscopy (excitation: 450 -490 nm, emission: 515 nm). Nuclei were stained with Hoechst 33342 (100 mol/L).
Cytotoxicity. Cell viability was determined using the MTT-assay (25) and the neutral red assay (26), with slight modifications. Briefly, for measurement of flavonoid toxicity, 10,000 cells/well (96-multiwell dish) were plated; for protective effects 25,000 cells/well (24-multiwell dish) were plated. Color development (20 mg/L MTT, 16 mg/L neutral red) was performed for 3 h.
Lipid peroxidation. Malondialdehyde (MDA) 5 was quantified by the thiobarbituric acid assay and subsequent HPLC (27) as described earlier (24) .
Apoptotic DNA-fragmentation. DNA was isolated using phenol: chloroform extraction and oligonucleosomal fragmentation of DNA was analyzed electrophoretically as described earlier (24) .
Caspase activity. Colorimetrically labeled substrates for VDVADase activity (caspase-2), DEVDase activity (caspase-3/7), and LEHDase activity (caspase-9) were used according to the manufacturer's protocol (Calbiochem).
DNA strand breaks ("comet assay"). Cells (3 ϫ 10 6 ) were seeded out in a 6-well dish and incubated 24 h later with either flavonoid alone for 3 h or with 500 mol/L H 2 O 2 (2 h) in the presence or absence of a preincubation (1 h) with flavonoids. For determination of DNA strand breaks, the comet assay (28) was used.
Microscopic analysis of nuclear fragmentation. To investigate nuclear fragmentation as a further feature of apoptotic cell death, fluorescent staining with Hoechst 33342 (100 mol/L) was used as described earlier (24) .
TEAC assay. Trolox equivalent antioxidative capacity (TEAC) was determined as described earlier (29) , and absorption was measured after 4 min of mixing the substances with the ABTS solution.
Protein. Protein concentration was determined spectrophotometrically according to Bradford (30) using bovine serum albumin as the standard.
Statistics. Data are given as means Ϯ SEM of at least 3 independent experiments. The significance of differences was assessed WÄ TJEN ET AL.using 1-way ANOVA followed by the LSD test (Analyze-it). Differences were considered significant at P Ͻ 0.05.
RESULTS
Antioxidative effects of flavonoids in a cell-free system. Myricetin (3 hydroxyl groups in the B-ring) showed the strongest antioxidative effect in the TEAC assay. Quercetin, fisetin, morin, and catechin (2 hydroxyl groups in the B-ring) also exhibited good antioxidative properties. The capacities of taxifolin and rutin to decolorize the ABTS radical were the lowest of the flavonoids analyzed but were in the same range as that of the synthetic antioxidant Trolox itself which was used as the reference compound ( Table 1 ).
Effects of flavonoids on H 2 O 2 -induced DNA strand breakage in H4IIE cells. Hydrogen peroxide produced a dose-and time-dependent increase in DNA strand breakage as measured by alkaline single-cell electrophoresis. The increase reached a plateau at concentrations Ͼ500 mol/L, a concentration at which the DNA of almost every cell was fragmented (data not shown). Incubation with 500 mol/L H 2 O 2 for 2 h increased the image length from 14.01 Ϯ 0.26 m (control, no "comettail") to 56.07 Ϯ 4.7 m. The order of protective potency against H 2 O 2 -induced DNA strand break formation of the 7 flavonoids tested differed markedly from the order of their antioxidant potential measured in vitro in the TEAC assay. In preincubation experiments, the flavonoids quercetin and fisetin protected against H 2 O 2 -mediated DNA strand breaks in a dose-dependent manner. Preincubation with 10 mol/L quercetin or 25 mol/L fisetin decreased the H 2 O 2 -induced strand breaks by ϳ50% (Fig. 2A) . Preincubation with other flavonoids at a concentration of 50 mol/L caused only minor (taxifolin, myricetin) or no reduction (morin, rutin, catechin) in H 2 O 2 -mediated DNA strand breakage ( Table 1) .
Effects of quercetin and fisetin on H 2 O 2 -mediated apoptosis and cytotoxicity. H 2 O 2 caused apoptosis in H4IIE cells. Incubation with 1000 mol/L H 2 O 2 increased caspase-3 activity (1497 Ϯ 235% of control value) after an incubation time of 15 h; after this peak, activity decreased again likely due to secondary necrotic events (data not shown). Quercetin and fisetin at a concentration of 25 mol/L reduced the increase in caspase-3 activation caused by 1000 mol/L H 2 O 2 by ϳ50% (Fig. 2B ). Quercetin and fisetin at 10 mol/L provided ϳ50% protection against the loss of cell viability induced by 150 -250 Table 1) .
Uptake of flavonoids. To investigate whether the difference of in vitro and in vivo potency of the flavonoids was due to differences in cellular uptake, we analyzed their intracellular concentration by HPLC at different incubation times (0.5-24 h). Quercetin, fisetin, morin, taxifolin, and myricetin were detected in the cells after 1 h of incubation although to a very different extent (quercetin Ͼ fisetin Ͼ Ͼ morin Ͼ Ͼtaxifolin Ͼ myricetin, Table 1 ) which might explain why only quercetin and fisetin are protective in the cells. Rutin and catechin were not taken up by H4IIE cells even after an incubation of 24 h. Incubation with 50 mol/L quercetin led to an intracellular concentration of 0.82 Ϯ 0.14 nmol/10 6 cells. Quercetin uptake was not saturated at high concentrations [3.5 Ϯ 0.7, 33.4 Ϯ 10.7, and 109 Ϯ 21 nmol quercetin/10 6 cells after incubation (1 h) with 250, 500, and 750 mol/L quercetin, respectively].
The intracellular concentration of quercetin decreased exponentially with time (15.9 Ϯ 4.7, 9.7 Ϯ 3.5, and 1.7 Ϯ 0.6 mmol quercetin/10 6 cells after 2, 4, and 8 h, respectively) due to its metabolism; 3 peaks at 13.53, 13.78, and 15.61 min were identified as glucuronidated metabolites of quercetin due to spectral characteristics and MS fragmentation spectra. The m/z of [M-H]-ions was 477, which were fragmented to [M-H]-ions with an m/z of 301. We further analyzed the intracellular distribution of quercetin in the cells by fluorescence microscopy. After 1 h of incubation with 50 mol/L quercetin, a bright nuclear fluorescence was observed, suggesting that the flavonoid accumulates in the nucleus (Fig. 3) .
Cytotoxicity of flavonoids. The intrinsic cytotoxicity of the 7 flavonoids differed greatly. Although quercetin [50% effective concentration (EC 50 ) ϭ 35 Ϯ 4 mol/L] and fisetin (EC 50 ϭ 48 Ϯ 3 mol/L) were relatively toxic, taxifolin, rutin, and catechin (up to 500 mol/L) did not reduce cell viability (no EC 50 determined). The order of cytotoxic potential in H4IIE cells was quercetin Ͼ fisetin Ͼ myricetin Ͼ morin Ͼ taxifolin ϭ catechin ϭ rutin using the MTT assay and thus roughly resembled the order of cellular uptake. With the neutral red assay, quercetin and morin exhibited a lower toxicity than in the MTT assay, whereas the toxicity of the other flavonoids remained almost the same ( Table 2) , suggesting that mitochondria are a more sensitive target of these 2 flavonoids. After 3 h of incubation, the time at which the comet assay was performed, no EC 50 could be determined for all flavonoids tested up to concentrations of 500 mol/L (data not shown). Contribution of oxidative stress to flavonoid-induced cytotoxicity. Preincubation of H4IIE cells with antioxidants (50 mol/L ␣-tocopherol, 500 mol/L ascorbic acid, 500 mol/L N-acetylcysteine, 1000 mol/L glutathione) or the metal chelator desferoxamine (25 mol/L) did not protect against quercetin-induced cytotoxicity. In the case of ascorbic acid, a further increase in flavonoid-mediated cytotoxicity occurred (data not shown). Incubation of H4IIE cells with high concentrations of flavonoids (up to 500 mol/L) for 24 h did not increase the formation of MDA, a marker of oxidative stress ( Table 2) .
Induction of DNA strand breaks by flavonoids. Incubation of H4IIE cells with quercetin increased comet formation in a time-and concentration-dependent manner. A doseresponse curve was found with saturation at 250 mol/L (500 mol/L quercetin: image length, 36.0 Ϯ 5.7 m). Fisetin also induced DNA breakage (Fig. 4) . There was a slight increase in DNA strand breaks after incubation with morin but no increase in DNA "comet" formation after incubation with taxifolin, rutin, catechin, or myricetin ( Table 2) .
Induction of apoptosis by flavonoids. The ability of flavonoids to induce apoptotic cell death was investigated first by analyzing oligonucleosomal-sized DNA fragmentation (DNA ladder formation). Although myricetin and taxifolin induced apoptosis only at high concentrations (500, 1000 mol/L), quercetin induced DNA ladder formation between 100 and 500 mol/L and fisetin was the most potent apoptosis-inducing flavonoid with effective concentrations as low as 50 mol/L (Fig. 5A) . Induction of apoptosis by quercetin and fisetin was confirmed by measurement of caspase activation. Incubation with 250 mol/L quercetin and fisetin for 24 h increased caspase-2 activity, caspase-3 activity, and caspase-9 activity by 100 -500% (Fig. 5B) . Apoptotic cell death was further confirmed for quercetin by the demonstration of cellular blebbing and nuclear fragmentation (Fig. 5C ). Quercetin (500 mol/L) increased condensed and fragmented nuclei with an apoptotic index of 32.4 Ϯ 1.47 (control: 1.8 Ϯ 0.56).
DISCUSSION
It was the major aim of our study to determine the margin of exposure for cytoprotective and cytotoxic actions of flavonoids in a cell culture system. We achieved this with 2 of the compounds tested, quercetin and fisetin, which were readily taken up by the cells. Protection against H 2 O 2 -induced cytotoxicity, DNA strand breaks, and caspase-3 activation were detected at 10 -25 mol/L of quercetin and fisetin. On the other hand, these compounds induced cytotoxicity, DNA strand breaks, oligonucleosomal DNA fragmentation, and caspase-3 activation on their own at concentrations between 50 and 250 mol/L. This finding is of interest because it may be possible to distinguish a cytoprotective dose range from a proapoptotic dose range. To protect human health, the latter range should be avoided in the consumption of flavonoidcontaining food supplements, but may be appropriate in an attempt to support cancer chemotherapy by flavonoid drugs. It should be noted, however, that the 2 dose ranges overlap to a certain extent. For instance, on the one hand, 50 mol/L fisetin significantly protected against the large number of DNA strand breaks caused by 500 mol/L H 2 O 2 (from 54 to 22 m) but can itself induce DNA strand breaks to a minor extent at this concentration (22 m) in the absence of H 2 O 2 .
All flavonoids tested proved to be good antioxidants in a cell-free assay; their potency equaled that of the standard antioxidant, Trolox. However, the pharmacologic activity of the flavonoids tested did not correlate with their antioxidant potential measured in this in vitro assay. The data suggest that this might be due to differences in cellular uptake. There was a convincing relation between cellular uptake and both cytoprotective and proapoptotic actions indicating that these events require the presence of the compounds in the cell. Intrinsic cytotoxicity of the flavonoids, however, does not fit into this scheme. Morin and myricetin in particular had only low intracellular concentrations, but their cytotoxicity was comparable to that of quercetin and fisetin. Various explanations for the cytotoxicity of flavonoids have been proposed, including the inhibition of enzymes such as protein kinase C, cGMP-dependent protein kinase, adenylate cyclase, DNA topoisomerases, or glutathione S-transferase (1, 23) , leading to disturbances in cell cycle, for example, followed by apoptotic or necrotic events. There are several ways in which a flavonoid could exert pharmacologic activity in the absence of cellular uptake, e.g., extracellular H 2 O 2 formation may occur (31, 32) . Alternatively, the attack may take place at a membrane structure, e.g., a growth hormone receptor. For the green tea polyphenol, epigallocatechin gallate, the existence of a cell surface receptor was suggested (33). Myricetin and morin caused growth inhibition in HT29 cells at concentrations very similar to those that led to cytotoxicity in our study (47 or 117 mol/L, respectively) and myricetin activated caspase-3 in these cells but not in MCF-7 cells and LLC-PK1 cells (17) . In our study the apoptosis-inducing potential of myricetin in H4IIE cells was negligible.
Controversy exists concerning whether the cytotoxic and DNA-damaging effects of flavonoids involve the formation of reactive oxygen species. In our study, we did not find evidence for increased lipid peroxidation even at high concentrations of flavonoids. Also, no protection against quercetin-and fisetininduced cytotoxicity was achieved by a number of antioxidants, indicating that ROS production may not be involved. Incubation of human lymphocytes with high concentrations of quercetin increased DNA strand breakage but did not induce oxidative damage to DNA bases (22) . Yamashita et al. (34) reported that the quercetin-induced DNA damage was dependent on the presence of copper(II)-ions because it was inhibited by bathocuproine, a copper-specific chelator. We investigated the effects of desferoxamine on quercetin-induced cytotoxicity but again found no protective effects.
Only limited conclusions can be derived from our results with respect to the structure-activity relation of the compounds tested. We demonstrated that the antioxidative potential in vitro of the flavonoids increased with the number of their phenolic hydroxyl groups because myricetin, which has the highest number of hydroxyl groups, exhibited the strongest antioxidant action in the TEAC assay. In view of the correlation between intracellular concentration and the range of pharmacologic activity that includes protective, DNA-damaging, and apoptotic effects, structural hindrance is likely to occur at the level of cellular uptake. It was shown previously that the rutinoside moiety of flavonoids inhibits membrane crossing (35) ; therefore the inactivity of rutin was not unexpected. It cannot be excluded that in addition to uptake, the intracellular actions of the flavonoids are also influenced by structural differences. Current results do not allow us to distinguish these 2 levels of effect. In any case, it appears that the double bond in the ring C causing the planarity of the ring system is supportive but not sufficient for uptake and/or biological activity.
Quercetin is one of the most abundant flavonoids in the diet; it is also considered to be one of the most promising members of this class for both general chemoprevention and cancer chemotherapy. For this reason, the pharmacokinetics of quercetin were studied repeatedly in rats as well as in humans. Manach et al. (36) reported that rats fed quercetin (single meal, 0.2%) exhibited constant plasma concentrations of quercetin metabolites of ϳ50 mol/L for at least 16 h. Rats adapted to quercetin (0.2%) maintained plasma concentrations of ϳ100 mol/L (quercetin ϩ metabolites). The authors suggested that the elimination of quercetin metabolites is low and that high plasma concentrations are easily maintained with a regular supply of quercetin in the diet. More data on the pharmacokinetics of quercetin in humans are also available. Both the aglycone and the glucosides can enter the body via the small intestine, whereas other conjugates can be taken up only after hydrolysis by colonic bacteria (37,38). One study with 4 doses (250 mg)/day of quercetin administered as capsules resulted in plasma concentrations of 1.5 mol/L (39); however, later studies using quercetin glucosides yielded relatively higher plasma concentrations, i.e.,7 mol/L after quercetin-4Ј-O-glucoside equivalent to 100 mg quercetin (40), 4.5 mol/L after 150 mg quercetin 4Ј-glucoside, and 5 mol/L after 150 mg quercetin 3-glucoside (41) . When administered in onions (a plant source that contains quercetin as glucosides) the following plasma concentrations of total quercetin as related to dose were reported: 0.05 mol/L after 15 mg (42), 0.63 mol/L after 68 -94 mg (43), 7.65 mol/L after 100 mg (40) , and 4 mol/L after 300 mg (44) . Half-lives between 10 and 30 h were reported (40, 41, 45) , suggesting that continuous daily intake will result in a steady-state concentration. All kinetic variables measured in humans were measured in plasma, and no information on flavonoid concentrations in different tissues is available. In some studies, no free quercetin was found in blood samples [e.g., (43) ], whereas in others, free quercetin was detected (46) . Isorhamnetin is the only phase I metabolite described (40) . It is unclear at present whether the metabolites still possess pharmacologic activity. Data suggest that flavonoids can be deglucuronidated at the site of action, e.g., in endothelial cells (47,48). In contrast to quercetin, data on fisetin plasma concentrations in humans are lacking, probably because it is minimally present in the diet. Fisetin, like quercetin, is methylated in human liver (49) . Taken together, the data on quercetin pharmacokinetics in humans suggest that a dietary supplement of 1-2 g of quercetin, an amount proposed by supplement makers, may result in plasma concentrations exceeding 10 mol/L but probably not exceeding 50 mol/L if taken properly.
In summary, we found that quercetin and fisetin were readily taken up into H4IIE cells and protected against H 2 O 2 -induced cytotoxicity, DNA strand breaks, and apoptosis at concentrations of 10 -25 mol/L; however, these compounds themselves induced cytotoxicity, DNA strand breaks, oligonucleosomal DNA fragmentation and caspase activation at concentrations between 50 and 250 mol/L. The other flavonoids tested were good antioxidants in a cell-free assay; their pharmacologic activity did not correlate with in vitro antioxidant potential but rather with cellular uptake. Our data suggest that cytoprotective concentrations of some flavonoids are lower by a factor of 5-10 than their DNA-damaging and proapoptotic concentrations. These results have implications also for humans in terms of risk assessment and in the modulation of isolated food constituents; they should be carefully studied because flavonoids are used increasingly in dietary supplements.
